Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-08

Clinical Trial Update: Adrenal Artery Ablation Treats Primary Aldosteronism [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial on adrenal artery ablation for treating primary aldosteronism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Third Military Medical University | Conditions: Primary Aldosteronism, Hypertension | Phase 3 | Status: COMPLETED